Devin Blass

Direttore Tecnico/Scientifico/R&S presso LONGEVERON INC.

Patrimonio netto: 340 871 $ in data 31/05/2026

40 anni

Health Technology

Health Services

Consumer Services

Profilo

Mr. Devin Blass is a Chief Technology Officer & Senior Vice President at Longeveron, Inc. Mr. Blass was previously employed as a Senior Vice President-Comprehensive Cell Solutions by New York Blood Center, Inc., a Vice President-Technical Operations by Talaris Therapeutics, Inc., a Head-Cell Manufacturing Operations by Bellicum Pharmaceuticals, Inc., and a Director-Commercial Program Manufacturing by Mesoblast, Inc. He received his undergraduate degree from Texas State University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valutazione	Data di valutazione
LONGEVERON INC. CLASS A 1,46%	01/05/2026	441.543 ( 1,46% )	340 871 $	31/05/2026

Posizioni attive di Devin Blass

Società	Posizione	Inizio
LONGEVERON INC.	Direttore Tecnico/Scientifico/R&S	02/12/2024

Tutte le posizioni attive di Devin Blass

Precedenti posizioni note di Devin Blass

Società	Posizione	Fine
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Corporate Officer/Principal	-
BELLICUM PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
Mesoblast, Inc. Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products	Corporate Officer/Principal	-
TOUE BIOPAR	Direttore operativo	-

Vedi nel dettaglio l'esperienza di Devin Blass

Formazione di Devin Blass

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Devin Blass

Società collegate

Aziende private	6
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Health Services
Mesoblast, Inc. Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products	Health Technology
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer	Health Technology
Texas State University Texas State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Longeveron, Inc. Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions	Health Technology